Schonfeld Strategic Advisors LLC Lineage Cell Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $15.4 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.2 - $1.53 $26,760 - $34,119
22,300 New
22,300 $33,000
Q2 2021

Aug 16, 2021
SELL
$2.17 - $3.0 $72,855 - $100,722
-33,574 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.77 - $3.1 $28,038 - $49,107
15,841 Added 89.33%
33,574 $78,000
Q4 2020

Feb 16, 2021
BUY
$0.95 - $1.83 $16,846 - $32,451
17,733 New
17,733 $32,000

Others Institutions Holding LCTX

# of Institutions
134
Shares Held
106M
Call Options Held
22.1K
Put Options Held
0
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $115M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email